HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.

Abstract
We compared a novel unpolyglutamable antifolate, MX-68, with polyglutamable antifolate, methotrexate (MTX), for treatment of an autoimmune kidney disease which develops spontaneously in MRL/Mp-lpr/lpr (MRL/lpr) mice. Oral administration of either MX-68 or MTX was commenced in 8-week-old female mice and continued 3 times a week until they reached 30 weeks of age. MX-68 delayed the onset of proteinuria and prolonged life span dose-dependently. Furthermore, it suppressed the elevation of serum blood urea nitrogen and cholesterol levels. MX-68 was as effective as MTX at ameliorating events which accompany the development of lupus nephritis, despite that MX-68 did not undergo polyglutamation. These ameliorative effects of MX-68 and MTX did not occur via inhibition of either autoantibody production or cell proliferation. Neither compound suppressed age-dependent elevation of immune complexes or antibodies for single-stranded DNA and TNP in serum nor did they influence the associated enlargement of lymph nodes and spleen. We conclude that MX-68 is beneficial for the treatment of autoimmune kidney disease in mice and may be useful for other related diseases such as systemic lupus erythematosus.
AuthorsM Mihara, N Takagi, K Urakawa, Y Moriya, Y Takeda
JournalInternational archives of allergy and immunology (Int Arch Allergy Immunol) Vol. 113 Issue 4 Pg. 454-9 (Aug 1997) ISSN: 1018-2438 [Print] Switzerland
PMID9250591 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • DNA, Single-Stranded
  • Folic Acid Antagonists
  • N-(1-((2,4-diamino-6-pteridinyl)methyl)-3,4-dihydro -2H-1,4-benzothiazine-7-carbonyl)-L-2-aminoadipic acid
  • Picrates
  • 2-Aminoadipic Acid
  • Cholesterol
  • picric acid
  • Methotrexate
Topics
  • 2-Aminoadipic Acid (administration & dosage, analogs & derivatives, chemistry, therapeutic use)
  • Administration, Oral
  • Animals
  • Antigen-Antibody Complex (analysis)
  • Autoantibodies (analysis, metabolism)
  • Autoimmune Diseases (drug therapy, prevention & control)
  • Blood Urea Nitrogen
  • Cell Division (drug effects)
  • Cholesterol (blood, metabolism)
  • DNA, Single-Stranded (immunology)
  • Dose-Response Relationship, Drug
  • Female
  • Folic Acid Antagonists (administration & dosage, therapeutic use)
  • Kidney Diseases (drug therapy, immunology, prevention & control)
  • Lupus Nephritis (drug therapy, prevention & control)
  • Lymph Nodes (pathology)
  • Methotrexate (administration & dosage, analogs & derivatives, chemistry, therapeutic use)
  • Mice
  • Mice, Inbred MRL lpr
  • Picrates (immunology)
  • Proteinuria (drug therapy, prevention & control)
  • Specific Pathogen-Free Organisms
  • Spleen (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: